Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.
Pennington, L.F., Tarchevskaya, S., Brigger, D., Sathiyamoorthy, K., Graham, M.T., Nadeau, K.C., Eggel, A., Jardetzky, T.S.(2016) Nat Commun 7: 11610-11610
- PubMed: 27194387 
- DOI: 10.1038/ncomms11610
- Primary Citation of Related Structures:  
5HYS - PubMed Abstract: 
Omalizumab is a widely used therapeutic anti-IgE antibody. Here we report the crystal structure of the omalizumab-Fab in complex with an IgE-Fc fragment. This structure reveals the mechanism of omalizumab-mediated inhibition of IgE interactions with both high- and low-affinity IgE receptors, and explains why omalizumab selectively binds free IgE ...